BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29772243)

  • 1. Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents.
    Jabeen M; Choudhry MI; Miana GA; Rahman KM; Rashid U; Khan HU; Arshia ; Sadiq A
    Steroids; 2018 Aug; 136():22-31. PubMed ID: 29772243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
    Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel carbapenem chalcone derivatives: synthesis, cytotoxicity and molecular docking studies.
    Kommidi DR; Pagadala R; Rana S; Singh P; Shintre SA; Koorbanally NA; Jonnalagadda SB; Moodley B
    Org Biomol Chem; 2015 Apr; 13(14):4344-50. PubMed ID: 25767041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of newly synthesized progesterone derivatives on apoptotic and angiogenic pathway in MCF-7 breast cancer cells.
    Yahya SMM; Abdelhamid AO; Abd-Elhalim MM; Elsayed GH; Eskander EF
    Steroids; 2017 Oct; 126():15-23. PubMed ID: 28797724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.
    Coşkun GP; Djikic T; Hayal TB; Türkel N; Yelekçi K; Şahin F; Küçükgüzel ŞG
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
    El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
    Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
    Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
    Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of targeted dibenzo[b,f]thiepines and dibenzo[b,f]oxepines as potential lead molecules with promising anti-breast cancer activity.
    Ansari MI; Hussain MK; Arun A; Chakravarti B; Konwar R; Hajela K
    Eur J Med Chem; 2015 Jun; 99():113-24. PubMed ID: 26067208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic effect on cancer cell lines and macrophages of novel progesterone derivatives having an ester or a carbamate function at C-3 and C-17.
    Chávez-Riveros A; Garrido M; Ramírez Apan MT; Zambrano A; Díaz M; Bratoeff E
    Eur J Med Chem; 2014 Jul; 82():498-505. PubMed ID: 24937183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
    Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [
    Linares-Anaya O; Avila-Sorrosa A; Díaz-Cedillo F; Gil-Ruiz LÁ; Correa-Basurto J; Salazar-Mendoza D; Orjuela AL; Alí-Torres J; Ramírez-Apan MT; Morales-Morales D
    Molecules; 2021 May; 26(9):. PubMed ID: 34066820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents.
    Tang Z; Wu C; Wang T; Lao K; Wang Y; Liu L; Muyaba M; Xu P; He C; Luo G; Qian Z; Niu S; Wang L; Wang Y; Xiao H; You Q; Xiang H
    Eur J Med Chem; 2016 Aug; 118():328-39. PubMed ID: 27176944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study.
    Branowska D; Karczmarzyk Z; Wolińska E; Wysocki W; Morawiak M; Urbańczyk-Lipkowska Z; Bielawska A; Bielawski K
    Molecules; 2020 May; 25(10):. PubMed ID: 32429377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
    Chinthala Y; Thakur S; Tirunagari S; Chinde S; Domatti AK; Arigari NK; K V N S S; Alam S; Jonnala KK; Khan F; Tiwari A; Grover P
    Eur J Med Chem; 2015 Mar; 93():564-73. PubMed ID: 25743216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors.
    Ravula P; Vamaraju HB; Paturi M; Sharath Chandra JNGN
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29205467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.